| # | Drug | Count |
|---|---|---|
| 0 | METHOTREXATE | 2 |
| 1 | METHOTREXATE SODIUM | 2 |
| 2 | OLANZAPINE | 2 |
| 3 | OLANZAPINE PAMOATE | 2 |
| 4 | ACETAMINOPHEN | 1 |
| 5 | ACETAMINOPHEN 500MG | 1 |
| 6 | ACETAMINOPHEN TABLET EXTENDED RELEASE | 1 |
| 7 | ADALIMUMAB | 1 |
| 8 | CEFEPIME | 1 |
| 9 | CEFEPIME HYDROCHLORIDE | 1 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | CLINDAMYCIN PHOSPHATE | 1 | 0.0002 |
| 1 | PERFLUTREN | 1 | 0.0002 |
| 2 | MITOXANTRONE HYDROCHLORIDE | 1 | 0.0002 |
| 3 | PEGASPARGASE | 1 | 0.0001 |
| 4 | LABETALOL | 1 | 0.0001 |
| 5 | CEFEPIME HYDROCHLORIDE | 1 | 0.0001 |
| 6 | OLANZAPINE PAMOATE | 2 | 0.0000 |
| 7 | IMATINIB MESYLATE | 1 | 0.0000 |
| 8 | VINCRISTINE SULFATE | 1 | 0.0000 |
| 9 | LISDEXAMFETAMINE DIMESYLATE | 1 | 0.0000 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Contrast Agent for Ultrasound Imaging [EPC] | 1 | 0.0002 |
| 1 | Asparagine-specific Enzyme [EPC] | 1 | 0.0001 |
| 2 | CTLA-4-directed Blocking Antibody [EPC] | 1 | 0.0000 |
| 3 | Complement Inhibitor [EPC] | 1 | 0.0000 |
| 4 | Programmed Death Receptor-1 Blocking Antibody [EPC] | 1 | 0.0000 |
| 5 | beta-Adrenergic Blocker [EPC] | 2 | 0.0000 |
| 6 | Folate Analog Metabolic Inhibitor [EPC] | 2 | 0.0000 |
| 7 | Opioid Agonist [EPC] | 1 | 0.0000 |
| 8 | Dihydropyridine Calcium Channel Blocker [EPC] | 1 | 0.0000 |
| 9 | Corticosteroid [EPC] | 1 | 0.0000 |